Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Amerika
Bluebird bio Inc
Nieuws
Bluebird bio Inc
BLUE
NAS
: BLUE
| ISIN: US09609G1004
3/05/2024
0,900 USD
(-0,39%)
(-0,39%)
3/05/2024
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
6 mei 2024 ·
Levi & Korsinsky Notifies Shareholders of bluebird bio, Inc.(BLUE) of a Class Action Lawsuit and an Upcoming Deadline
· Persbericht
2 mei 2024 ·
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
· Persbericht
25 april 2024 ·
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
· Persbericht
22 april 2024 ·
Lost Money on bluebird bio, Inc.(BLUE)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
· Persbericht
18 april 2024 ·
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
· Persbericht
17 april 2024 ·
May 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BLUE
· Persbericht
15 april 2024 ·
bluebird bio, Inc. Class Action: Levi & Korsinsky Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 - BLUE
· Persbericht
10 april 2024 ·
May 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BLUE
· Persbericht
8 april 2024 ·
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio Lawsuit - BLUE
· Persbericht
3 april 2024 ·
bluebird bio, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your Rights - BLUE
· Persbericht
1 april 2024 ·
Shareholders that lost money on bluebird bio, Inc.(BLUE) should contact Levi & Korsinsky about pending Class Action - BLUE
· Persbericht
24 juli 2021 ·
BLUEBIRD BIO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of bluebird bio, Inc. - BLUE
· Persbericht
12 april 2021 ·
BLUE INVESTOR FILING DEADLINE TOMORROW : Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against bluebird bio, Inc.
· Persbericht
18 maart 2021 ·
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in bluebird bio, Inc. of Class Action Lawsuit and Upcoming Deadline - BLUE
· Persbericht
18 maart 2021 ·
BLUE INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against bluebird bio, Inc.
· Persbericht
12 maart 2021 ·
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in bluebird bio, Inc. of Class Action Lawsuit and Upcoming Deadline - BLUE
· Persbericht
4 maart 2021 ·
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
· Persbericht
3 maart 2021 ·
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in bluebird bio, Inc. of Class Action Lawsuit and Upcoming Deadline - BLUE
· Persbericht
2 maart 2021 ·
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages bluebird bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - BLUE
· Persbericht
19 februari 2021 ·
BLUE Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against bluebird bio, Inc. (NASDAQ: BLUE); Lead Plaintiff Deadline is April 13, 2021
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe